Point of Care Diagnostic Market Size, Share & Trends Analysis, By Product (Glucose Monitoring Products, Infectious Disease Testing Products), By Purchase (OTC Testing Products, Prescription-based Testing Products), By Region and Forecast Period 2022 – 2030

Report ID - MRC_2193 | Pages - 208 | Category - Healthcare and Pharma

Point of care diagnostic Market Insights:

The Point of Care Diagnostic Market was analyzed which was worth USD 35.4 Billion in the year 2021, expecting a CAGR of 7.03% during the forecast period (2022-2030), and the market is projected to be valued at USD 65.25 Billion by 2030.

Point-of-Care (POC) diagnostics refers to medical testing that is performed near the location where the patient is being treated. The purpose of POC testing is to obtain rapid results, which can then be used to guide medical decision-making. The global point-of-care diagnostic market is expected to grow due to the increasing demand for rapid, convenient, and cost-effective medical testing.

How much is the Point of Care Diagnostic Market worth ?

img

Get Free Sample PDF

Market Dynamics:

Drivers:

The growing demand for rapid, convenient, and cost-effective medical testing is the primary driver of the point-of-care diagnostic market. The increasing prevalence of chronic diseases, the growing aging population, and the focus on patient-centered care are also driving the growth of the market. The growing adoption of home-based healthcare and telemedicine, along with the increasing focus on preventive healthcare, are providing growth opportunities for the market. The increasing investment in research and development and the launch of new and innovative POC diagnostic devices are also contributing to the growth of the market.

Restraints:

Some of the major restraints include the high cost of POC diagnostic devices, the lack of standardization and regulatory approval for many POC diagnostic tests, limited reimbursement for POC diagnostic tests, a lack of awareness about these tests, and a shortage of trained personnel to operate POC diagnostic devices. Furthermore, the limited availability of POC diagnostic tests in developing countries, combined with insufficient infrastructure and resources, as well as low healthcare spending in these regions, are also impeding market growth. These restraints are limiting the growth of the point-of-care diagnostic market and need to be addressed in order to achieve further growth in the market.

Opportunity:

The point-of-care diagnostic market offers growth potential for market players due to increasing demand for rapid, convenient, and cost-effective medical testing. Adoption of home-based healthcare and telemedicine, focus on preventive healthcare, investment in R&D, and launch of innovative POC diagnostic devices are contributing to market growth. Significant growth opportunities exist in untapped markets in developing countries with increasing healthcare spending. New technologies such as nanotechnology and lab-on-a-chip also present growth opportunities.

COVID-19 Impact:

The COVID-19 pandemic has affected the point-of-care diagnostic market both positively and negatively. Increased demand for rapid diagnostic tests and shift to home-based healthcare boosted demand for POC diagnostic devices. However, pandemic-induced supply chain disruptions caused shortages of devices and consumables, and slowed down R&D and launch of new POC devices. Decreased healthcare spending due to economic impact also impacted market growth. Overall, the impact of COVID-19 on the market has been mixed.

Point of care diagnostic Market Report Coverage:

Report AttributesReport Details
Study Timeline2016-2030
Market Size in 2030 (USD Billion)65.25 Billion
CAGR (2022-2030)7.03 %
By ProductGlucose Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Fecal Occult Testing Products, Cardiometabolic Monitoring Products, Pregnancy & Fertility Testing Products, Cholesterol Testing Products, Cancer Marker Testing Products, Urinalysis Testing Products, Haematology Testing Products, Drugs-of-abuse Testing Products, Other POC Products
By PurchaseOTC Testing Products, Prescription-based Testing Products
By PlatformLateral Flow Assays, Immunoassays, Microfluidics, Molecular Diagnostics, Dipsticks
By End UserProfessional Diagnostic Centers, Research Laboratories, Home Care, Others
By GeographyNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
Key PlayersJohnson and Johnson, Siemens AG, Nova Biomedical, Danaher Corporation, bioMrieux SA, Abbott Laboratories, Hoffmann La Roche Ltd, Sinocare Inc., Sysmex corporation, Becton Dickinson and Company

Get Free Sample PDF

Market Segmentation:

By Product

The Glucose Monitoring Products segment is expected to hold a significant share of the market due to the increasing prevalence of diabetes. The Infectious Disease Testing Products segment is expected to grow at a significant rate due to the increasing demand for rapid diagnostic tests for infectious diseases. The Coagulation Monitoring Products segment is expected to grow due to the increasing demand for POC testing for coagulation disorders. The other segments, such as Fecal Occult Testing Products, Cardiometabolic Monitoring Products, Pregnancy & Fertility Testing Products, Cholesterol Testing Products, Cancer Marker Testing Products, Urinalysis Testing Products, Haematology Testing Products, Drugs-of-abuse Testing Products, and Other POC Products, are also expected to grow due to the increasing demand for POC diagnostic tests in various applications.

By Purchase

The point-of-care diagnostic market can be segmented by purchase into two categories: OTC Testing Products and Prescription-based Testing Products. OTC Testing Products refer to over-the-counter tests that can be purchased without a prescription, such as pregnancy tests and glucose monitoring devices. Prescription-based Testing Products refer to tests that require a prescription from a healthcare provider, such as infectious disease testing products and cancer marker testing products.

By Platform

The POC diagnostic market is segmented by platform into Lateral Flow Assays, Immunoassays, Microfluidics, Molecular Diagnostics, Dipsticks. Lateral Flow uses paper-based tests for quick, simple, cost-effective diagnoses. Immunoassays detect antigens with antibodies, widely used in POC testing. Microfluidics manipulates small fluid volumes in POC diagnostic devices. Molecular Diagnostics detects DNA/RNA sequences, growing in POC testing. Dipsticks use paper strips to detect substances in samples, simple diagnostic tests.

By Region

The Point of care diagnostic market is segmented by region into North America, Europe, Asia Pacific, Middle East and Africa, and South America. The North American POC diagnostic market is driven by the presence of well-established healthcare infrastructure and the high adoption of innovative diagnostic technologies. The region holds a major share in the global market and is expected to continue its dominance over the forecast period. The Asia-Pacific POC diagnostic market is driven by the rapidly increasing population, rising awareness about early disease detection, and improving healthcare infrastructure. The region is expected to be the fastest-growing market during the forecast period. The Europe market in the region is expected to grow at a significant pace during the forecast period.

Point of care diagnostic Market Competitive Landscape:

The Point of Care Diagnostic Market is highly competitive and consists of a large number of players. Some of the major players in the market include:

  • Johnson and Johnson
  • Siemens AG
  • Nova Biomedical
  • Danaher Corporation
  • bioMrieux SA
  • Abbott Laboratories
  • Hoffmann La Roche Ltd
  • Sinocare Inc.
  • Sysmex corporation
  • Becton Dickinson and Company

These players are focusing on product innovation and development, partnerships, and collaborations to expand their market presence and increase their market share. For instance, Roche Diagnostics has launched a range of innovative point of care diagnostics products, while Johnson & Johnson has entered into partnerships with several companies to expand its product portfolio.

Merger & Acquisition:

Some of the recent mergers and acquisitions in the point-of-care diagnostic market include the acquisition of Alere by Abbott Laboratories, the acquisition of Cholestech by Roche Diagnostics, and the acquisition of Biosite by Inverness Medical Innovations.

Recent developments:

Recent developments in the Point of Care Diagnostic market include the launch of new and innovative products by major players, such as Roche Diagnostics’ cobas Liat System and Abbott Laboratories’ i-STAT Alinity System. Companies are also expanding their presence through mergers and acquisitions, such as Johnson & Johnson’s acquisition of Sight Diagnostics and Becton, Dickinson and Company’s acquisition of CUBRC, Inc. Siemens Healthineers has also entered the market with its Atellica Solution. These developments showcase the focus of companies on product innovation and market expansion.

Table of Content

To check our Table of Contents, please mail us at: [email protected]

Research Methodology

The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.

Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.

Point of Care Diagnostic Market Size, Share & Trends Analysis, By Product (Glucose Monitoring Products, Infectious Disease Testing Products), By Purchase (OTC Testing Products, Prescription-based Testing Products), By Region and Forecast Period 2022 – 2030
Back to top button